Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „statins“
Suchtreffer
Begriffe & Kennungen
Angiostatine
Eintrag öffnenBryostatine
Eintrag öffnenCPIC · SLCO1B1, ABCG2, CYP2C9, and Statins
Eintrag öffnenCholestagel · 4.5 · Statins When Cholestagel was co-administered with statins in clinical studies, an expected add-on LDL-C loweri
Eintrag öffnenCholestagel · 4.8 · 6 Cholestagel in combination with statins and in combination with ezetimibe was well tolerated and the adverse
Eintrag öffnenCholib · 4.5 · Other statins and fibrates Gemfibrozil increases the AUC of simvastatin acid by 1.9-fold, possibly due to inhi
Eintrag öffnenCholib · 4.5 · Other statins and fibrates Gemfibrozil increases the AUC of simvastatin acid by 1.9-fold, possibly due to inhi
Eintrag öffnenCystatine
Eintrag öffnenDiacomit · 4.5 · - Statins (atorvastatin, simvastatin, etc.) Increased risk of dose-dependent adverse reactions such as rhabdom
Eintrag öffnenDiacomit · 4.5 · - Statins (atorvastatin, simvastatin, etc.) Increased risk of dose-dependent adverse reactions such as rhabdom
Eintrag öffnenDiacomit · 4.5 · - Statins (atorvastatin, simvastatin, etc.) Increased risk of dose-dependent adverse reactions such as rhabdom
Eintrag öffnenDiacomit · 4.5 · - Statins (atorvastatin, simvastatin, etc.) Increased risk of dose-dependent adverse reactions such as rhabdom
Eintrag öffnenEfient · 4.5 · 5 Statins: Atorvastatin (80 mg daily) did not alter the pharmacokinetics of prasugrel and its inhibition of pl
Eintrag öffnenEndostatine
Eintrag öffnenEntresto · 4.5 · OATP1B1 and OATP1B3 substrates, e.g. statins In vitro data indicate that sacubitril inhibits OATP1B1 and OATP1
Eintrag öffnenEntresto · 4.5 · OATP1B1 and OATP1B3 substrates, e.g. statins In vitro data indicate that sacubitril inhibits OATP1B1 and OATP1
Eintrag öffnenEvrenzo · 4.5 · Interactions are also expected with other statins. When co-administered with roxadustat, adverse reactions ass
Eintrag öffnenHistatine
Eintrag öffnenHydroxymethylglutaryl-CoA-Reductase-Inhibitoren
Eintrag öffnenIbrance · 4.5 · Concomitant use of palbociclib with statins which are substrates of CYP3A4 and/or BCRP may increase the risk o
Eintrag öffnen